Momenta Pharmaceuticals, Inc. (MNTA)

[floblu14]

Despite trial setback, Momenta shares surge on generics news and buyout rumors Aug 8, 2016, 7:06am EDT

Over the next couple of months, the company expects decisions both in the U.S. Patent and Trademark Office and in civil courts that could help clear the way for the launch of the higher-dose versions, which could dramtically increase the company’s revenues next year.

Both the sales of the existing generic and the potential for the higher-dose one have fueled a stock increase.

One of the prime buyers seems to be Mylan (Nasdaq: MYL), with whom Momenta has a partnership to develop biosimilars. At 12:30 p.m. point, the company’s stock was up 26 percent, though it settled back down over the afternoon to close up 13 percent to $12.48.

On a call with analysts after the Q2 report, comments by Wheeler seemed to reinforce the potential for the partnership between Momenta and Mylan.

http://www.bizjournals.com/boston/blog/bioflash/2016/08/despite-trial-setback-momenta-shares-surge-on.html?ana=yahoo&yptr=yahoo